MFS
AST

MSI Financial Services’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

MSI Financial Services’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34
Closed – – 4245
2016
Q3 		$0 Hold
34
– – ﹤0.01% 4278
2016
Q2 		$0 Hold
34
– – ﹤0.01% 4324
2016
Q1 		$0 Hold
34
– – ﹤0.01% 4321
2015
Q4 		$0 Hold
34
– – ﹤0.01% 4166
2015
Q3 		$0 Hold
34
– – ﹤0.01% 3604
2015
Q2 		$0 Buy
+34
New +$326 ﹤0.01% 3457

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSI Financial Services's AST Position: Q4 2016 in Review

MSI Financial Services sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2016, closing a stake of 34 shares.

MSI Financial Services first reported a position in AST in Q2 2015 and held it in 6 quarters. The position peaked at $0 in Q3 2016. 66 funds tracked by Wall St. Rank hold AST as of Q4 2016.

  • MSI Financial Services reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2016 after selling out during the quarter.
  • MSI Financial Services sold 34 Asterias Biotherapeutics Inc. Series A shares in Q4 2016.
  • MSI Financial Services first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 6 quarters.
  • MSI Financial Services's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q3 2016.
  • 66 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.